• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 9
  3. Author

Online ISSN: 2515-8260

Volume7, Issue9

Anti-oxidant, Anti Inflammation and Anti diabetic Activity of Novel Schiff Base of Derived from 2-Hydroxy benzoic acid (4-Chloro benzylidine)-Hydrazide and 2-Hydroxy benzoic acid (3,4-Dimethoxy benzylidine)-Hydrazide

    V.Anusuya, G. Sujatha, G. L. Balaji

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 9, Pages 1760-1769

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

            A series of new 2-Hydroxy benzoic acid (4-Chloro benzylidine)-Hydrazide and 2-Hydroxy benzoic acid (3, 4-Dimethoxy benzylidine)-Hydrazide based Schiff base derivatives, have been synthesized. Synthezied Schiff base ligands were screened for anti- oxidant, anti-inflammation, and anti-diabetic activity. The compounds were screened for their Antioxidant activity was evaluated by DPPH radical scavenging method and compared with standard ascorbic acid.Anti inflammation activity were examined by albumin denatuation and compared with standard aspine. antidiabetic activity against α-amylase enzyme and compared with standard drug acarbose.
Keywords:
  • PDF (243 K)
  • XML
(2020). Anti-oxidant, Anti Inflammation and Anti diabetic Activity of Novel Schiff Base of Derived from 2-Hydroxy benzoic acid (4-Chloro benzylidine)-Hydrazide and 2-Hydroxy benzoic acid (3,4-Dimethoxy benzylidine)-Hydrazide. European Journal of Molecular & Clinical Medicine, 7(9), 1760-1769.
V.Anusuya, G. Sujatha, G. L. Balaji. "Anti-oxidant, Anti Inflammation and Anti diabetic Activity of Novel Schiff Base of Derived from 2-Hydroxy benzoic acid (4-Chloro benzylidine)-Hydrazide and 2-Hydroxy benzoic acid (3,4-Dimethoxy benzylidine)-Hydrazide". European Journal of Molecular & Clinical Medicine, 7, 9, 2020, 1760-1769.
(2020). 'Anti-oxidant, Anti Inflammation and Anti diabetic Activity of Novel Schiff Base of Derived from 2-Hydroxy benzoic acid (4-Chloro benzylidine)-Hydrazide and 2-Hydroxy benzoic acid (3,4-Dimethoxy benzylidine)-Hydrazide', European Journal of Molecular & Clinical Medicine, 7(9), pp. 1760-1769.
Anti-oxidant, Anti Inflammation and Anti diabetic Activity of Novel Schiff Base of Derived from 2-Hydroxy benzoic acid (4-Chloro benzylidine)-Hydrazide and 2-Hydroxy benzoic acid (3,4-Dimethoxy benzylidine)-Hydrazide. European Journal of Molecular & Clinical Medicine, 2020; 7(9): 1760-1769.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 279
  • PDF Download: 489
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus